Osilodrostat and Treatment of Cushing's Disease

Oct 30, 2020, 03:56 PM

Headliner
Share
Subscribe
Dr. Georgiana Dobri, a neuroendocrinologist with Weill Cornell Medicine, discusses the approval of osilodrostat and management of Cushing's disease in 2020.
Share
Subscribe
Next
Jeffrey Curtis, MD: Osteoporosis in 2020
Top episodes
Tirzepatide and the Future of Incretin Therapies, with Timothy Garvey, MD
by Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Key Updates in ADA Standards of Care—2024
by Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Semaglutide & Tirzepatide Updates at ESC Congress 2025
by Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives